ER
GDRX icon

EVR Research’s GoodRx Holdings GDRX Stock Holding History

EVR Research’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,300,000
Closed -$5.73M – 36
2025
Q1 		$5.73M Buy
1,300,000
+921,337
+243% +$4.32M 1.62% 19
2024
Q4 		$1.76M Buy
+378,663
New +$2.08M 0.59% 32

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

EVR Research's GDRX Position: Q2 2025 in Review

EVR Research sold out of GoodRx Holdings (GDRX) in Q2 2025, closing a stake of 1,300,000 shares — an estimated $5.73M sold.

EVR Research first reported a position in GDRX in Q4 2024 and held it in 2 quarters. The position peaked at $5.73M in Q1 2025. 182 funds tracked by Wall St. Rank hold GDRX as of Q2 2025.

  • EVR Research reported no remaining GoodRx Holdings position as of Q2 2025 after selling out during the quarter.
  • EVR Research sold 1,300,000 GoodRx Holdings shares in Q2 2025, an estimated $5.73M.
  • EVR Research first reported a position in GoodRx Holdings in Q4 2024 and held it in 2 quarters.
  • EVR Research's GoodRx Holdings position peaked at $5.73M in Q1 2025.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2025.

Based on EVR Research's 13F filing for Q2 2025, filed 14 Aug 2025.